Caxton Associates LP Care Dx, Inc. Transaction History
Caxton Associates LP
- $3.12 Billion
- Q4 2024
A detailed history of Caxton Associates LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 33,619 shares of CDNA stock, worth $427,633. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,619
Previous 36,280
7.33%
Holding current value
$427,633
Previous $1.13 Million
36.48%
% of portfolio
0.02%
Previous 0.04%
Shares
9 transactions
Others Institutions Holding CDNA
# of Institutions
232Shares Held
56.9MCall Options Held
51.2KPut Options Held
46K-
Black Rock Inc. New York, NY5.29MShares$67.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$61.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.67MShares$33.9 Million0.01% of portfolio
-
State Street Corp Boston, MA2.48MShares$31.6 Million0.0% of portfolio
-
Bamco Inc New York, NY2.19MShares$27.9 Million0.12% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $680M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...